Rosuvastatin-d6 (sodium salt) – 1 mg

Brand:
Cayman
CAS:
2070009-41-3
Storage:
4
UN-No:
Non-Hazardous - /

Rosuvastatin-d6 is intended for use as an internal standard for the quantification of rosuvastatin (Item Nos. 12029 | 18813) by GC- or LC-MS. Rosuvastatin is an HMG-CoA reductase inhibitor (IC50 = 5 nM).{15309,15082} It is a fully-synthetic inhibitor that is designed to maximize the points of contact with, and inhibition of, HMG-CoA reductase.{15309} Formulations containing rosuvastatin reduce low-density lipoprotein and C-reactive protein and increase high-density lipoprotein in humans.{16178,30471}  

 

Available on backorder

SKU: 23359 - 1 mg Category:

Description

An internal standard for the quantification of rosuvastatin by GC- or LC-MS


Formal name: (3R,5S,E)-7-(4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl-1,1,1,3,3,3-d6)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate, monosodium salt

Synonyms: 

Molecular weight: 509.6

CAS: 2070009-41-3

Purity: ≥98%

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cardiovascular System|Blood|Acute Phase Reactants||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins